SYRE - Spyre Therapeutics, Inc.
IEX Last Trade
24.02
0.155 0.645%
Share volume: 7,393
Last Updated: Thu 26 Dec 2024 08:30:27 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$23.86
0.16
0.65%
Summary score
35%
Profitability
50%
Dept financing
14%
Liquidity
75%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
110.99%
Return on assets
-18.05%
Return on sales
-6919.06%
Return on invested capital
274.54%
Total debt ratio
32.18%
Debt ratio change over timeo
-0.79%
Current Ratio
6.37%
Quick Ratio
6.37%
Cash Position Ratio
6.06%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
517.36%
Return on assets
-16.74%
Return on sales
-23146.22%
Return on invested capital
122.48%
Total debt ratio
62.68%
Debt ratio change over timeo
-0.51%
Current Ratio
6.92%
Quick Ratio
6.92%
Cash Position Ratio
6.87%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-28.8%
Return on assets
-9.8%
Return on sales
0%
Return on invested capital
103.22%
Total debt ratio
68.77%
Debt ratio change over time
-0.79%
Current Ratio
11.38%
Quick Ratio
11.38%
Cash Position Ratio
11.32%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
33.47%
Return on assets
-110.81%
Return on sales
-5007.76%
Return on invested capital
41.9%
Total debt ratio
-79.06%
Debt ratio change over time
-0.79%
Current Ratio
2.33%
Quick Ratio
2.33%
Cash Position Ratio
2.16%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SYRE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 110.99% | 13.79% | 34.47% | 7.43% |
| Return on assets | -18.05% | 2.76% | 3.15% | 5.62% |
| Return on sales | -6919.06% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 274.54% | 2.36% | 5.39% | 19.77% |
| Profitability | 50% | 33% | 42% | 53% |
| Total debt ratio | 32.18% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.79% | 308.97% | -6.99% | 1.18% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 6.92% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.92% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.87% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 18% | 41% |
| Short-term ratios | SYRE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 517.36% | 13.77% | 13.25% | 3.8% |
| Return on assets | -16.74% | 2.43% | 1.89% | 3.09% |
| Return on sales | -23146.22% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 122.48% | 2.14% | 3.39% | 9.18% |
| Profitability | 50% | 41% | 36% | 52% |
| Total debt ratio | 62.68% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.51% | 46.38% | -72.08% | 1.51% |
| Dept financing | 17% | 50% | 25% | 7% |
| Current Ratio | 6.92% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.92% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.87% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 19% | 47% |